Compare First Solar, Inc. (FSLR) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Solar, Inc. vs Regeneron Pharmaceuticals Inc — how do they compare? First Solar, Inc. trades at $241.6 (market cap $25.89B), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 3.2× First Solar, Inc.'s market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while First Solar, Inc. pays none. Which is the better fit depends on your goals.
| FSLR | REGN | |
|---|---|---|
Market Cap | $25.89B | $82.06B |
Sector | Technology | Health |
52-Week High | $318.30 | $812.27 |
52-Week Low | $180.05 | $555.51 |
Enterprise Value | $24.36B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About First Solar, Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and a new factory under construction in India.
Read more on FSLR →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
